Impact of Predictive Genetic Testing on Quality of Life and Health-related Behaviour
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 241
- 主要终点
- Quality of Life assessed by the SF-36 questionnaire [followed by its scale information in the Description]
研究概览
简要总结
Analysing Impact of preemptive genetic testing on quality of life, physical activity and eating behavior at baseline and 3 months after testing.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age ≥18 years
- •informed consent for genetic testing
- •informed consent for study participation
排除标准
- •Age <18 years
- •renal replacement dependency
- •pregnancy
- •active cancer disease
- •no informed consent for genetic testing or study participation
结局指标
主要结局
Quality of Life assessed by the SF-36 questionnaire [followed by its scale information in the Description]
时间窗: 3 months
Short form (36) (SF-36) questionnaire evaluates health related quality of life (Scale 0-100)
Physical activity assessed by the IPAQ questionnaire [followed by its scale information in the Description]
时间窗: 3 months
International Physical Activity Questionnaire (IPAQ) evaluates physical activity in MET(metabolic equivalent)/min/week
Eating behavior assessed by the modified LEI questionnaire [followed by its scale information in the Description]
时间窗: 3 months
The modified Luzerner Ernaehrungs Index (LEI) questionnaire evaluates eating behavior at lunch (Scale 1-4 per item; 1=never; 4=daily)
次要结局
- Satisfaction with check up and genetic testing: Likert scale (1-10)(3 months)
研究者
Prof. Dr. med. Mark Dominik Alscher
Medical Director, Managing Director
Robert Bosch Medical Center